FEBRUARY 12, 2014

Company

TherapeuticsMD, Inc.

Filed

February 12, 2014

Accession Number

0001013594-14-000117

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →